Gunvor Ekman-Ordeberg

Gunvor Ekman-Ordeberg is a notable inventor based in Danderyd, Sweden. He has made significant contributions to the field of obstetric medicine, particularly in the area of labor management. With a total of 6 patents to his name, his work has the potential to improve outcomes for pregnant women.

Latest Patents

Ekman-Ordeberg's latest patents include innovative methods for facilitating labor in pregnant women. One of his key inventions is the medical use of tafoxiparin, which is directed towards its application in the spontaneous onset of labor in term pregnant women. This method involves administering tafoxiparin in a daily dose ranging from 30 to 320 mg. Another significant patent focuses on the use of sulfated glycosaminoglycans for establishing effective labor. This method treats protracted labor by administering a depolymerized low molecular weight heparin, which is designed to prime or curatively treat the cervix and myometrium, thereby aiding in the progression of labor.

Career Highlights

Gunvor Ekman-Ordeberg has established himself as a leading figure in obstetric innovation. His work at Dilafor AB has been instrumental in developing new treatments that address common challenges faced during labor. His research and inventions have garnered attention for their potential to enhance maternal and fetal health.

Collaborations

Throughout his career, Ekman-Ordeberg has collaborated with esteemed colleagues, including Anders Malmström and Lena Degling-Wikingsson. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Gunvor Ekman-Ordeberg's contributions to obstetric medicine through his innovative patents demonstrate his commitment to improving labor management for pregnant women. His work continues to influence the field and offers hope for better outcomes in maternal care.

Profile summary based on public USPTO records.